Amorphous calcium phosphate, a precursor phase of the bone mineral in vertebrates, is limited owing to its instability. A simple wet-chemical precipitation method was developed in this study to prepare stable and nanosized amorphous calcium phosphates doped with citrate using orthophosphoric acid, anhydrous critic acid, and anhydrous calcium chloride as the raw materials in an alcohol system at room temperature. The structure of the obtained nanosized amorphous calcium phosphate doped with citrate was evaluated by an X-ray diffraction analysis, Fourier transform-infrared spectroscopy, X-ray photoelectron spectrometry, high-resolution transmission electron microscopy and selected area electron diffraction. In addition, Ca and P ions release profile was investigated in the simulated bodily fluid solution for two weeks, and the biological performance was evaluated using in vitro mineralization and cell viability studies. The results demonstrated that the synthetic specimens in the presence of citrate had a similar structure, and their dimensions were in the nanoscale. Furthermore, the specimens possessed excellent apatite mineralization ability in simulated bodily fluid solution and a stimulatory effect on the cell viability of mouse bone-marrow stem cells. The S0.050 specimen displayed the maximum amount of Ca (152.5 ppm) and P (81 ppm) ions release at the third day and the best bioactivity and cell viability. Based on all of the results, it was concluded that the stability and bioactivity of nanosized amorphous calcium phosphates were improved by doping with citrate. Thus, bone graft substitutes could potentially be modified by the addition of citric acid to affect their performance in bone repair and regeneration.